Abstract Background: Little is known regarding the cognitive impairment in subjects with early, drug-naive Parkinson disease (PD). The aim of this study was to explore the proportion with mild cognitive impairment (MCI) and subtypes in an incidence cohort of untreated… Continue Reading

Michael Brainin, Chair of the EFNS Scientific Committee

by Sandro Marini We describe the case of a Caucasian 18-year-old woman self referred to the emergency department because of numbness in her right hand and dyplopia. Approximately one week earlier, the patient gradually began to feel as if her… Continue Reading

The national Medical Specialist Associations in Europe are represented at the European level by the European Union of Medical Specialists (UEMS). To harmonise and improve the quality of Continuing Medical Education (CME) UEMS delegated the task of accreditation to UEMS… Continue Reading

Swedish Neurological Society – past, present and future challenges by Martin Gunnarsson During the 19th century, neuroscience was established as a very important research area in the Swedish scientific community (see article by professor Sten Fredrikson in the May issue… Continue Reading

Authors and academics are in revolt against the tyranny of the giant publishing houses. There is a swing towards the growing numbers of free on line journals. Which side should the EFNS join in this rebellion?

One of my main interests in the field of Neurology is the study and treatment of Cerebrovascular Disorders. Stroke, the main representative of this issue, is the leading cause of disability and the second most common cause of death worldwide.

In order to benefit from the lower early registration rate,
please make sure to register by June 18, 2012. Please visit the congress website and register at: http://www2.kenes.com/efns/reg/Pages/Reg.htm   EFNS 2012: Don’t miss the early registration deadline! was last modified:… Continue Reading

The 2012 participants and winners of a travel grant to Stockholm and a free congress registration are: Tournament 1 – Clinical neurology
Sunday, 09 September 2012, 11:00-12:30h Barbara Casolla, France
Marian Galovic, Switzerland
Pietro Guaraldi, Italy
Roman Schniepp, Germany
Alba… Continue Reading

The congress quiz is online now until June 6, 2012: http://www.kenes.com/efns2012/quiz/ Answer all questions correctly, and you will perhaps win a free registration to the 16th EFNS congress in Stockholm, Sweden, September 8-11, 2012.   The EFNS Congress Quiz was… Continue Reading

2200 abstracts submitted to 16th EFNS Congress, Stockholm, Sweden The call for abstracts to be submitted for presentation at the 16th EFNS Congress, Stockholm, Sweden, September 08-11, 2012, was answered with a strong response of 2200 contributions. This number again… Continue Reading

All e-learning activities are free-of-charge for EFNS members, who are registered to www.efns.org! Answer all questions correctly and you will receive one hour of CME. European Journal of Neurology Every month one article is chosen for online learning. The following… Continue Reading

The work done by the European Board of Neurology (EBN) is impressive and the EFNS is very grateful. If the EBN did not exist the EFNS would have had to invent it and do the work ourselves. As it is we enjoy an intimate relationship with EBN. Two members of the EFNS sit on the EBN, Dr Marianne de Visser and Dr David Vodušek, and we have invited the President of the EBN to attend and speak to the Council of the EFNS in September in Stockholm. Clearly the training of our neurologists is of the utmost importance to European neurology. The care with which the EBN revised Chapter 6 of its educational charter incorporating the neurology training curriculum deserves our applause and thanks.

Abstract: Objective: To report the results of a 24-month extension of a phase II trial assessing the efficacy, safety, and tolerability of the once-daily oral sphingosine-1-phosphate receptor modulator, fingolimod (FTY720), in relapsing multiple sclerosis (MS).
Methods: In the randomized, double-blind,… Continue Reading

Philip Scheltens, Chair of the EFNS Scientist Panel Cognitive Neurology and Dementia